Are there subgroups of chronic fatigue syndrome? An exploratory cluster analysis of biological markers

Abstract

Background Chronic fatigue syndrome (CFS) is defined according to subjective symptoms only, and several conflicting case definition exist. Previous research has discovered certain biological alterations. The aim of the present study was to explore possible subgroups based on biological markers within a widely defined cohort of adolescent CFS patients and investigate to what extent eventual subgroups are associated with other variables. Methods The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial (NorCAPITAL) has previously performed detailed investigation of immunological, autonomic, neuroendocrine, cognitive and sensory processing functions in an adolescent group of CFS patients recruited according to wide diagnostic criteria. In the present study, hierarchical cluster analyses (Ward’s method) were performed using representative variables from all these domains. Associations between clusters and constitutional factors (including candidate genetic markers), diagnostic criteria, subjective symptoms and prognosis were explored by standard statistical methods. Results A total of 116 patients (26.7% males, mean age 15.4 years) were included. The final cluster analyses revealed six clusters labelled pain tolerant & good cognitions, restored HPA dynamics, orthostatic intolerance, low-grade inflammation, pain intolerant & poor cognitions, and high vagal (parasympathetic) activity, respectively. There was substantial overlap between clusters. The pain intolerant & poor cognitions-cluster was associated with low functional abilities and quality of life, and adherence to the Canada 2003 diagnostic criteria for CFS. No other statistically significant cluster associations were discovered. Conclusion Within a widely defined cohort of adolescent CFS patients, clusters could be delineated, but no distinct subgroups could be identified. Associations between clusters and constitutional factors, subjective symptoms and prognosis were scarce. These results question the clinical usefulness of searching for CFS subgroups, as well as the validity of the most “narrow” CFS diagnostic criteria. Trial registration: Clinical Trials NCT01040429

A comparison of pain, fatigue, and function between post–COVID-19 condition, fibromyalgia, and chronic fatigue syndrome: a survey study

“…98 Participants were asked 4 questions relating to pain intensity, and 7 questions pertaining to pain interference with general activity, with higher scores indicating greater pain severity and interference. Scores for the BPI pain severity and interference range from mild pain (1-3), moderate pain (4)(5)(6), to severe pain (7-10). 98,130 2.3.1.5.…”

“…Because of the complex nature and spectrum of symptoms in FMS and CFS, several studies have reported patient subgroups based on self-report measures, comorbidities, sociodemographic, physiological, and psychological variables using cluster analysis. 4,31,76,109 Investigating multiple symptom domains and profiling patient subgroups of similar phenotype may help identify disease severity, direct treatment allocation, and improve treatment efficacy. 105,119,124 Given the overlap in clinical features between these cohorts, existing knowledge on FMS and CFS may aid in the rehabilitation of patients suffering from post-COVID-19.…”

Symptom-based clusters in people with ME/CFS: an illustration of clinical variety in a cross-sectional cohort

“…However, clustering was based on a limited number of symptoms or non-core (i.e. less frequently observed) symptoms [ 12 – 17 ], and/or a non-validated questionnaires was used to assess symptoms [ 16 , 18 ].…”

Scoping review of molecular biomarkers associated with fatigue, stress, and depression in stroke survivors: A protocol

“…A thorough understanding of the biomarkers associated with post-stroke symptoms, could provide biological measurement processes for follow up or early diagnosis. Limited studies have undertaken molecular biomarker analysis for post-stroke fatigue, although several have been conducted on the molecular biomarkers associated with chronic fatigue syndrome [19][20][21]. Furthermore, several serum and salivary biomarkers have been identified in stroke survivors experiencing stress and depression [22,23].…”